text,labels
Normal-weight subjects showed significant blood oxygen level-dependent responses in the ventromedial prefrontal cortex ( vmPFC ) to food aromas compared with responses induced by the odor of an inedible object .,3
Female : 35.6 % .,3
"PrEP is efficacious for HIV-1 prevention among women using DMPA and men whose partners use DMPA , suggesting PrEP could mitigate the potential increased HIV-1 acquisition and transmission risks that have been associated with DMPA use .",4
"The SSM 30 g may be an effective , noninvasive alternative to health care provider-administered intravenous , intramuscular , or oral opioids for the management of moderate-to-severe acute pain .",4
Normal - wei9ht subjects showed 8i9nificant blood 0xy9en level - dependent responses in the ventromedial prefrontal c0ktex (vmPFC) to food aromas compared with responses induced by the odor 0f an inedible u6ject.,3
Normal - wei9ht subjects showed significant blood oxygen 1eve1 - dependent ke8pon8es in the ventromedial prefrontal c0ktex (vmPFG) to fu0d aromas compared with responses indoced by the odor of an inedible u6ject.,3
Normal - weight subjects 8h0wed significant b1oud oxygen level - dependent responses in the ventromedial pkefkonta1 cortex (vmPFC) tu food aromas cumpaked with responses induced by the odor uf an inedi61e u6ject.,3
Normal - weight 8u6ject8 8huwed 8i9nificant blood 0xy9en 1eve1 - dependent responses in the ventromedial prefrontal cortex (vmPFC) to food akoma8 compared with responses induced by the odor of an inedible object.,3
Normal - weight subjects showed significant blood uxy9en level - dependent responses in the ventromedial prefrontal cortex (vmPFC) t0 food ar0ma8 cumpaked with responses induced 6y the ud0r 0f an inedible object.,3
N0kmal - weight subjects showed significant blood oxygen 1eve1 - dependent responses in the ventromedial pkefr0nta1 cortex (vmPFG) to food akoma8 c0mpaked with responses indoced by the odor of an inedible object.,3
Female: 35. b%.,3
Fema1e: 38. 6%.,3
Female: 38. 6%.,3
Female: 35. 6%.,3
Fema1e: 35. 6%.,3
Female: 35. 6%.,3
"PrEP is efficaci0o8 for HIV - 1 prevention among women using DMPA and men whose partners use DMPA, suggesting PrEP could miti9ate the putentia1 increased H1V - 1 acquisition and tkansmi88iun risks that have 6een a880ciated with DMPA use.",4
"PrEP is efficacious fuk HIV - 1 prevention among women using DMPA and men whose partners use 0MPA, 8u99esting PkBP could mitigate the putentia1 increased H1V - 1 acquisition and transmission risks that have 6een associated with DMPA use.",4
"PrEP is efficaciuo8 for HIV - 1 prevention among w0men using OMPA and men whu8e partners use DMPA, suggesting PrEP could mitigate the potential increased HIV - I ac9oi8itiun and transmission risks that have been associated with 0MPA o8e.",4
"PrEP i8 efficacious f0k HIV - 1 prevention among women u8in9 DMPA and men wh08e partners o8e DMPA, su9ge8tin9 PrEP cuold miti9ate the potential increased HIV - 1 acquisition and transmission ri8rs that have been associated with DMPA use.",4
"PrEP i8 efficacious for HIV - 1 prevention among w0men using DMPA and men whose partners use DMPA, 8u9ge8ting PkBP could mitigate the putentia1 increased H1V - 1 ac9oi8itiun and tkansmi88i0n risks that have been associated with DMPA use.",4
"PrEP is efficaci0o8 for H1V - 1 prevention am0n9 women using OMPA and men whose partners use DMPA, suggesting PrEP c0old mitigate the potential increased HIV - I acquisition and transmission risks that have been associated with DMPA use.",4
"The SSM 39 9 may be an effective, noninvasive alternative to hea1th care provider - administered intravenous, intramuscular, or oral opioids for the management of mudekate - to - 8eveke acute pain.",4
"The SSM 30 9 may be an effective, noninvasive a1teknative tu health care pk0videk - administered intravenous, intramuscular, or oral opioids f0k the management uf mudekate - to - 8eveke acute pain.",4
"The SSM 30 9 may be an effective, noninvasive a1teknative to health care provider - administered intravenous, intramuscular, or oral opioids for the management 0f moderate - to - severe acote pain.",4
"The 88M 30 g may 6e an effective, noninvasive alternative to health cake provider - administered intkaven0o8, intramuscular, or 0kal 0pi0id8 for the management uf moderate - to - severe acote pain.",4
"The SSM 30 9 may be an effective, noninvasive alternative to health care pkuvidek - administered intkaven0o8, intramuscular, or 0kal opioids fuk the management of m0dekate - to - severe acote pain.",4
"The SSM 38 g may be an effective, noninvasive alternative to health care provider - administered intravenous, intkamo8colar, or oral opioids for the mana9ement uf moderate - to - 8eveke acote pain.",4
